Biphasic Levodopa-Induced Freezing of Gait in Parkinson's Disease

被引:8
|
作者
Nonnekes, Jorik [1 ,2 ]
Bloem, Bastiaan R. [3 ]
机构
[1] Radboud Univ Nijmegen, Ctr Expertise Parkinson & Movement Disorders, Donders Inst Brain Cognit & Behav, Med Ctr,Dept Rehabil, Nijmegen, Netherlands
[2] Sint Maartensklin, Dept Rehabil, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Expertise Parkinson & Movement Disorders, Med Ctr,Dept Neurol, Nijmegen, Netherlands
关键词
Gait; freezing of gait; levodopa; Parkinson's disease; parkinsonism; biphasic;
D O I
10.3233/JPD-201997
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The relation between freezing of gait in Parkinson's disease and levodopa is complex. Here, we describe a new phenotype of freezing of gait, namely levodopa-induced freezing of gait with a biphasic pattern. Our observation supports the idea that freezing of gait might emerge because of a mismatch between cognitive/limbic loops and motor loops involved in gait control. Moreover, it underscores the importance of assessing the influence of dopaminergic medication in daily clinical practice, including objective assessment in all three dopaminergic states. The possibility of biphasic freezing will only emerge after such a comprehensive evaluation, and will have immediate therapeutic consequences.
引用
收藏
页码:1245 / 1248
页数:4
相关论文
共 50 条
  • [21] Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia
    Yoo, Han Soo
    Choi, Yong Ho
    Chung, Seok Jong
    Lee, Yang Hyun
    Ye, Byoung Seok
    Sohn, Young H.
    Lee, Jong-Min
    Lee, Phil Hyu
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (11): : 2251 - 2260
  • [22] Future scenarios for levodopa-induced dyskinesias in Parkinson's disease
    Cerasa, Antonio
    Koch, Giacomo
    Fasano, Alfonso
    Morgante, Francesca
    FRONTIERS IN NEUROLOGY, 2015, 6
  • [23] Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease
    Cheshire, Perdita A.
    Williams, David R.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (03) : 343 - 348
  • [24] Levodopa-induced dyskinesia and neurocognitive function in Parkinson's disease
    Oggioni, G. D.
    Devoto, J.
    Cantello, R.
    Espay, A. J.
    MOVEMENT DISORDERS, 2012, 27 : S29 - S29
  • [25] Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease
    Metman, LV
    Del Dotto, P
    Natté, R
    van den Munckhof, P
    Chase, TN
    NEUROLOGY, 1998, 51 (01) : 203 - 206
  • [26] Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease
    Hoff, JI
    vander Plas, AA
    Wagemans, EAH
    van Hilten, JJ
    MOVEMENT DISORDERS, 2001, 16 (01) : 58 - 61
  • [27] Levetiracetam for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
    Stathis, P.
    Konitsiotis, S.
    Tagaris, G.
    Peterson, D.
    MOVEMENT DISORDERS, 2011, 26 (02) : 264 - 270
  • [28] Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease
    Merims, D
    Ziv, I
    Djaldetti, R
    Melamed, E
    LANCET, 1999, 353 (9166): : 1764 - 1765
  • [29] On Automated Assessment of Levodopa-Induced Dyskinesia in Parkinson's Disease
    Tsipouras, Markos G.
    Tzallas, Alexandros T.
    Fotiadis, Dimitrios I.
    Konitsiotis, Spyridon
    2011 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2011, : 2679 - 2682
  • [30] Pharmacokinetic factors and levodopa-induced dyskinesia in Parkinson's disease
    Oeda, T.
    Umemura, A.
    Tomita, S.
    Kohsaka, M.
    Park, K.
    Mori, Y.
    Sawada, H.
    MOVEMENT DISORDERS, 2015, 30 : S107 - S107